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Abstract 
The developmental origin of health and disease hypothesis states that adverse fetal and early child-
hood exposures can predispose to obesity, cardiovascular, and neurodegenerative diseases (NDDs) 
in adult life. Early exposure to environmental chemicals interferes with developmental program-
ming and induces subclinical alterations that may hesitate in pathophysiology and behavioral defi-
cits at a later life stage. The mechanisms by which perinatal insults lead to altered programming and 
to disease later in life are still undefined. The long latency between exposure and onset of disease, 
the difficulty of reconstructing early exposures, and the wealth of factors which the individual is 
exposed to during the life course make extremely difficult to prove the developmental origin of 
NDDs in clinical and epidemiological studies. An overview of animal studies assessing the long-
term effects of perinatal exposure to different chemicals (heavy metals and pesticides) supports the 
link between exposure and hallmarks of neurodegeneration at the adult stage. Furthermore, models 
of maternal immune activation show that brain inflammation in early life may enhance adult vul-
nerability to environmental toxins, thus supporting the multiple hit hypothesis for NDDs' etiology. 
The study of prospective animal cohorts may help to unraveling the complex pathophysiology of 
sporadic NDDs. In vivo models could be a powerful tool to clarify the mechanisms through which 
different kinds of insults predispose to cell loss in the adult age, to establish a cause-effect relation-
ship between "omic" signatures and disease/dysfunction later in life, and to identify peripheral bio-
markers of exposure, effects, and susceptibility, for translation to prospective epidemiological stud-
ies. 
KEYWORDS:  
Alzheimer’s disease; Exposome; Heavy metals; Maternal immune activation; Neurodevelopment; 
Parkinson’s disease; Pesticides 
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Abstract 
The developmental origin of health and disease hypothesis states that adverse fetal and early 
childhood exposures can predispose to obesity, cardiovascular, and neurodegenerative diseases 
(NDDs) in adult life. Early exposure to environmental chemicals interferes with developmental 
programming and induces sub-clinical alterations that may hesitate in pathophysiology and 
behavioral deficits at a later life stage. The mechanisms by which perinatal insults lead to altered 
programming and to disease later in life are still undefined. The long latency between exposure and 
onset of disease, the difficulty of reconstructing early exposures and the wealth of factors which the 
individual is exposed to during the life course, make extremely difficult to prove the developmental 
origin of NDDs in clinical and epidemiological studies. An overview of animal studies assessing the 
long-term effects of perinatal exposure to different chemicals (heavy metals and pesticides) 
supports the link between exposure and hallmarks of neurodegeneration at the adult stage. 
Furthermore, models of maternal immune activation show that brain inflammation in early life may 
enhance adult vulnerability to environmental toxins, thus supporting the multiple hit hypothesis for 
NDDs’ etiology. The study of prospective animal cohorts may help to unraveling the complex 
pathophysiology of sporadic NDDs. In vivo models could be a powerful tool to clarify the 
mechanisms through which different kinds of insults predispose to cell loss in the adult age, to 
establish a cause-effect relationship between “omic” signatures and disease/dysfunction later in life 
and to identify peripheral biomarkers of exposure, effects and susceptibility, for translation to 
prospective epidemiological studies. 
Keywords 
Neurodevelopment    Heavy metals    Pesticides     Maternal immune activation       
Alzheimer’s disease     Parkinson disease   Exposome 
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1. General Introduction 
 
 Since the publication in 1993 in The Lancet of the paper by Barker and co-workers (1993) 
indicating that fetal undernutrition was a major risk factor for cardiovascular diseases, a great body 
of experimental and epidemiological evidence has been accumulating, indicating that exposure to 
an unfavourable environment in early life is associated with a significantly increased risk of later 
disease, a phenomenon termed ‘early life programming’. The Barker’s hypothesis formed the basis 
for the developmental origins of health and disease (DOHaD) hypothesis that, further to fetal nutri-
tion, considered a wider spectrum of adverse fetal and childhood exposures that can predispose to 
chronic diseases later in life. In such expanded view of the original Barker's hypothesis, not only 
malnutrition, but also the quality of the maternal diet, the intake of micronutrients, maternal smok-
ing, and prenatal maternal stress may account for the relationship of the prenatal environment to 
adult disorders including cancer, metabolic, neuroendocrine, and neurodegenerative and cognitive 
diseases in adult life (Gillman 2005; Hanson 2013; Tarantal and Berglund 2014).  
 Knowledge about the mechanism(s) by which fetal insults lead to altered programming and 
to disease later in life is still scarce and, as discussed in the following paragraphs, it is mainly de-
rived from experimental studies. The long latency between exposure and disease and the lack of a 
clear pathological phenotype before disease onset make extremely difficult to assess the underlying 
mechanisms in clinical studies. Lahiri and co-workers (2009) suggested that environmental factors 
play a role in chronic disease etiology by inducing latent epigenetic changes. These authors de-
scribed the association of early environment with disease onset especially with respect to Alz-
heimer’s disease (AD), proposing a Latent Early-life Associated Regulation’ (LEARn) model that 
considers environmental exposures as ‘hits’. According to this model, all neurodegenerative disor-
ders come under the category of a ‘n’ hit latent model, where early life exposure leads to epigenetic 
perturbations in the genes, which remain silent until a second hit triggers the development of dis-
ease. The multiple hit hypothesis appears as particularly suited to explain the etiology of complex 
neuropsychiatric and neurologic diseases that share a highly sporadic nature characterized by genet-
ic and environmental risk factors. It also explains the relatively long latency between exposure and 
disease, as subclinical deficits occurring during specific windows of developmental plasticity do not 
become manifest without a second hit occurring later in life (Heindel et al. 2015). 
 The DOaHD models, to date, have focused mainly on skewed nutritional states and/or low 
birth weight (Morley 2006), while the role played by exposures to environmental agents, such as 
water and air pollution and chemicals in food, either alone or in combination, has only recently 
come to attention. This is somewhat surprising since there is vast literature on the developmental 
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neurotoxicity that indicates an inverse association between chemical exposure and child neurode-
velopment (Bellinger 2014 for an updated review).  Extensive evidence also shows that some envi-
ronmental agents alter developmental programming via changes in gene expression or imprinting 
that do not result in malformations but in functional deficits that become apparent later in life. 
However, much less attention has been posed to the role that early exposure to environmental  tox-
ins may play in predisposing to neurodegenerative and neuropsychiatric diseases in adult or even 
old age. This can be explained by several factors: the methodological constraints related to the diffi-
culty of establishing cause-effect relationships between early exposure and disease manifestation 
(discussed in section 2.4), the lack of reliable biomarkers that can predict increased risk in early life 
stages, together with the still diffused idea that neurodegenerative diseases (NNDs) are linked to 
pathological brain aging. 
 In the present review, we will describe the general frame of the developmental origin of 
NDDs, and the challenges posed to experimental and epidemiological research investigating the 
role of environmental pollutants as risk factors. We will then present an overview of animal studies 
that have assessed the delayed effects of either single or multiple perinatal toxic insults, evidencing 
neurobehavioral alterations resembling the major hallmarks of human NDDs.  
 
2. Developmental neurotoxicity and neurodegenerative diseases: a common playground?  
 
2.1 Introduction 
 The human nervous system develops over a very long period extending from the embryonic 
period through puberty. About two weeks after conception, the neural plate folds to form the neural 
tube, and cells formed during this period of rapid proliferation migrate to a different position where 
they differentiate into neurons and neuroglia. In the human fetus, cell migration is nearly complete 
in the neocortex and in most of the brain by the sixth month of gestation (Gupta et al. 2005). During 
the remainder of intrauterine development, neurons differentiate and connect with each other. The 
period of rapid synaptogenesis or the so-called brain growth spurt (in humans occurring between the 
last three months of pregnancy and the 2nd postnatal year) is considered one of the most important 
processes that take place during brain development (Garner et al. 2002). This process is crucial not 
only in neurodevelopment but also plays a vital role in synaptic plasticity, learning, memory, and 
adaptation throughout life. Without this process, no complex brain network can be established, as 
synapse is the fundamental unit of connectivity and communication between neurons (Tau and 
Peterson 2010). During the brain growth spurt substantially more connections are formed than those 
that will be eventually retained as many of them will be gradually discarded by apoptotic 
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mechanisms. The process of synapse elimination is a normal part of development (Tau and Peterson 
2010; Shonkoff 2000) and both endogenous (neurotrophic factors, synthesis and release of 
neurotransmitters, hormones) and environmental factors (i.e. sensorial inputs) concur to influence 
the fine matchup between pre- and postsynaptic neurons. Altogether, brain development is made up 
of several interactive and temporally overlapping stages. A plethora of mechanisms regulates each 
of these sequential steps, and some of the major signaling cascades and trophic factors in the 
developing brain play a role in the aging or neurodegenerating brain. In a recent review, Kovacs and 
co-workers (2014) highlighted the commonalities between neuronal loss and neuronal development. 
These authors performed an overview of NNDs according to major proteins deposited (i.e. 
amyloid and tau protein); they observed that genes that are mutated in neurodegenerative 
diseases code for protein that are highly expressed throughout neural development. Characterization 
of the mechanisms underlying hippocampal neurogenesis in the fetal and adult brain point to the 
involvement of the same gene products, namely of proteins that seem to drive either synaptogenesis 
or synaptic dysfunction depending on the age factor. This is the case of reelin, presenilins (PS), 
Notch-1 and brain-derived neurotrophic factor (BDNF). Furthermore, proteins representing 
hallmarks of NDDs might also play a crucial physiological role during brain development and adult 
neurogenesis. Specifically, the amyloid precursor protein (APP) significantly contributes to neurite 
outgrowth and hippocampal development (Billnitzer et al. 2013), -synuclein has a key role in 
synaptic vesicle recycling and is expressed in normal fetal brain, phosphorylation of the tau protein 
takes place during fetal development (Goedert et al. 1993). Altogether, though the majority of data 
originates from animal model research and still awaits confirmation in humans, there is substantial 
support to the view that pathological changes observed in NDDs could be in part the result of 
aberrant neuroplasticity mechanisms settled during the fetal life (Bugiani 2011). In this light, the 
study of the toxicants’ effects on brain development is possibly crucial for unravelling the complex 
NDDs etiology. 
 
2.2 Brain plasticity and vulnerability 
 
 The remarkable plasticity of the brain during the fetal and neonatal periods is a double-
edged sword as it renders this organ extremely responsive to environmental factors. On one hand, 
early environmental inputs can interact with genetic factors to promote neural circuit and functions 
development (Sale et al. 2014); on the other hand, early negative conditions (i.e. stress, toxic insults) 
can act in the opposite direction, increasing the chances to develop neurodevelopmental disorders or 
diseases in adulthood. Diverse environmental stressors - chemical pollutants, drugs, nutritional 
factors, maternal infection, stress, deprivation - may interfere with typical brain developmental 
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trajectories. In order to cope with insults perturbing prenatal environment, the fetus develops 
compensatory strategies that could be adaptive or disruptive, resulting in interindividual variability 
in the total neuronal and glial burden and functional reserve.  
 Exposure to toxicants at any point during brain development may result in aberrant neural 
structure or function. The end points affected may vary depending on the timing and duration of 
exposure. Toxic disruption of early maturational events are more likely to result in neural tube 
defects or major malformation (i.e. anencephaly, spina bifida), while toxic interference with later 
developmental events results more commonly in cytoarchitectural and molecular alterations that 
might be expressed as behavioral dysfunction. Specifically, damage or destruction of neurons by 
chemical compounds when they are in the process of synapses formation, integration and formation 
of neural networks will derange the organization and function of these networks, thereby setting the 
stage for subsequent impairment of learning and memory (Kovacs et al. 2014).  
 It was not until the early 1990s that significant evidence emerged showing that low-dose 
exposures to metals such as methylmercury and lead, though not producing teratogenic effects 
evident at birth could result in later behavioral dysfunctions in children (Gilbert et al. 1995; Banks 
et al. 1997). Similar results were later identified for the perinatal exposure to other environmental 
contaminants such as pesticides (Eskenazi et al. 2007; Perera et al. 2009), polychlorobiphenyls 
(Winneke 2001), polybrominated diphenyl ethers (Herbstman et al. 2010), and phthalates (Whyatt 
et al. 2012). These observations were consistent with the emergent DOHaD concept, and shifted the 
emphasis of developmental toxicology from the study of teratogenic effects to functional changes 
occurring during development and becoming manifest only after a latent period (Bellinger 2009; 
Miller 1986). Mechanistic studies carried out in animals and in in vitro models point to multiple 
pathways and targets of toxicity for several established neurotoxicants, depending on the dosage or 
time window of exposure (Neal et al., 2011; Roy et al., 2004; Slotkin and Seidler 2009). A 
reconsideration of the targets of toxicity of the major environmental pollutants in the developing 
brain could possibly reveal significant commonalities between pathophysiology of 
neurodevelopmental disorders and the cognitive decline associated to NDDs (see the case of 
developmental lead exposure, section 3.2.1). 
 
2.3 The multiple hit hypothesis for neurodegenerative diseases 
 Because the most of cases of NDDs onset late in life, they have been traditionally consid-
ered as linked to aging, but recent evidence suggests that the aging process is less important than 
was thought in the past. According to the LEARn model, all sporadic NNDs are characterized by 
´n´ hit latent model. Their onset in adulthood may be the consequence of alteration in gene regula-
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tion induced by early life exposures that, after a silent period, lead to disease. Under this perspective, 
the old age may be the point in time where any change in developmental programming produced by 
multiple hits interacts sufficiently to cause overt disease (Logroscino 2005). Under LEARn, early 
life stressors modify potential expression levels of disorder- associated genes in a latent manner. 
Latent changes in these genes are maintained by epigenetic mechanisms such as DNA methylation, 
DNA oxidation and chromatin reorganization. Alterations in gene expression lead to altered protein 
synthesis, and eventually to altered numbers and /or location of cells.  
 The multiple hit hypothesis firstly advanced to explain the etiology of PD (Calne and 
Langston 1985) might be applied to other major NNDs. In this light, the environmental insult could 
act via a one hit or even two/three hit scenario, where the fetal insult may be the first event. Fetal 
exposure to a toxicant would lead by itself to disease later in life, as the neurotoxicant may induce 
subclinical injury to neural or glial cells, which leads to progressive loss of function. The develop-
ing organism initially compensates for the mild deficit, but the functional reserve and plasticity of 
the brain would be overcome with time, and loss of function (including behavioral deficits) would 
appear (Rehul 1991). A mechanistic hypothesis proposed that early exposures to neurotoxic chemi-
cals reduce the number of neurons in critical areas of the brain, setting in motion a self-perpetuating 
process of neurodegeneration (Langston et al. 1999). In some cases, the fetal exposure needs to be 
combined with a neonatal exposure either to the same or different compound or to an adult exposure 
to cause the pathophysiology. Thus, the initial deficit would only be unmasked by subsequent ex-
ogenous influences (stress, disease, additional chemical exposure) or by the natural aging process 
(Costa et al. 2004).  
 
2.4 Environmental chemicals and neurodegenerative diseases: limits and constraints of epi-
demiological studies and the need of experimental models 
 A role for environmental toxicants in increasing risk of neurodegenerative diseases, such as 
PD and AD has been advanced based on case-control retrospective studies (Santibanez et al. 2007; 
Van Maele Fabry et al. 2012). Specifically, AD and PD have been associated to metals and pesticide 
occupational exposure, but data are far from being conclusive (Hertzman et al. 1990; Liou et al. 
1997). 
 Testing the hypothesis of the neurodevelopmental basis of NNDs in human population pre-
sents significant methodological problems. One of the most significant challenges is the issue of si-
lent toxicity, as the developing nervous system is endowed with marked ability to compensate for 
insults. At variance from neurodevelopmental disorders, exposures may have occurred many dec-
ades before the diagnosis of AD or PD; thus the assessment of chemical exposures is almost impos-
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sible to reconstruct in retrospective studies. In addition, the lack of reliable biomarkers makes diffi-
cult to obtain information on the fetal environment of an adult individual. Prospective studies link-
ing fetal exposure to adult diseases requires decades of follow-up, and may be confounded by mul-
tiple factors (i.e. co-exposure, life style, genetic vulnerability) modulating the risk of the original 
environmental insult. The methodological constraints widely recognized in neurodevelopmental 
toxicity studies, namely dose-response estimation, individual dimension of the exposure history and 
robustness of the clinical outcome (De Felice et al., 2015), are amplified by the “time” factor in 
studies on the developmental origin of NNDs. Of the 112 existing EU human cohorts established 
for studying NDDs, only five of them have followed people continuously from birth into adulthood; 
though many factors are currently under study (i.e. gene background, nutrition, life style) the issue 
of early exposure history is scarcely considered (JPND Action Group, 2013). 
Overall, the epidemiological and clinical data collected so far, while supporting the hypothesis of a 
contribution of environmental factors to NNDs, highlight the enormous difficulty of establishing 
causative links between each of these factors and the health outcome. The simultaneous exposure of 
an individual to multiple risk factors, which may interact in an additive, synergistic, or even antago-
nistic way along the life course remains to be explained and defined. Recently, the exposomic ap-
proach, considering all the endogenous and environmental factors to which an individual is exposed 
during the life span, has suggested a procedural framework to understand the fetal origin of adult 
diseases. In the exposome framework, the complex origin of human chronic diseases can be unfold-
ed by means of several omic signatures possibly describing exposure, effects, individual vulnerabil-
ity and their dynamic interplay (Wild 2012). However, peripheral biomarkers of exposure so far 
available for many environmental chemicals are indeed poor predictors of effects on the brain 
(Stangle et al. 2004); to complicate the picture further, in the case of late onset neurologic diseases 
biomarkers of effect should be able to capture early biological changes and predict later health ef-
fects.  
 In this framework, studies with laboratory rodents allow evaluation of important parameters, 
such as dose-response relationships, critical periods of susceptibility, and the relative contribution of 
genetic, epigenetic and environmental factors. So far, the use of animal models has been of 
paramount importance to investigate the mechanisms by which chemicals influence brain 
development in humans (Vorhees 1986). In particular, animal models are a powerful tool to test 
what combination of adverse environmental factors produce significant disruption of 
neurobehavioral development that lead to clinically relevant outcome in later stages. Notably, this 
kind of information can only be achieved by testing the living organism, as the face validity of an 
animal model of NDD consists primarily in a robust behavioral phenotype that can be associated to 
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the appearance of neurodegenerative features (Crawley 2012). 
 
3. Assessing the role of environmental exposures in neurodegenerative diseases' etiology: an 
overview of the in vivo models 
 
3.1 Introduction 
 The role of environmental chemicals and their mechanisms of action in the etiology of 
sporadic AD and PD have been extensively discussed in the recent review by Chin-Chan and co-
workers (2015). Based on epidemiological and experimental evidence, the authors identified 
neurotoxic metals, such as lead (Pb), mercury (Hg), aluminum (Al), cadmium (Cd), manganese (Mn) 
and arsenic (As), as well as some classes of pesticides as significant environmental risk factors. As 
mentioned above, most of studies suggesting association between these chemical agents and 
idiopathic AD or PD refer to occupational exposure (Santibanez et al. 2007; Firestone et al. 2010). 
Many are case-control studies (Parron et al. 2011) and very few population studies considered 
internal exposure to a specific compound in relation to disease occurrence (Richardson et al. 2014; 
Kim et al. 2015). The mechanisms by which chemicals with very different modes of action might 
promote neurodegeneration are still undetermined. For example, the pesticide class includes more 
than 1000 active ingredients including insecticides, herbicides and fungicides. Among those 
possibly implicated in AD or PD etiology, the organophosphorus compounds such as carbamates 
and organophosphate (OP) are potent inhibitors of acetylcholinesterase (AChE) and could affect 
APP processing (Giacobini et al. 1996); organochlorines (OC) can impair the functioning of the 
mitochondrial system and produce free radicals increasing oxidative stress and promoting cell death; 
bipyridyles such as paraquat (PQ) can generate free radicals that are able to cross the blood-brain 
barrier and damage neurons (Kumar et al. 2015). 
 In their extensive review, Chin-Chan et al. (2015) described several experimental studies (in 
vitro and in vivo) that have focused on metabolic pathways relevant for AD and PD pathogenesis. It 
is worth noting that in the large majority of the in vivo studies reviewed, rodents or non-human pri-
mates were exposed to chemicals at the adult stage. The metabolism of APP, phosphorylation of tau 
protein, aggregation of -synuclein, production of proinflammatory cytokines and reactive oxygen 
species generation appear as common targets of metals and pesticides' neurotoxicity following adult 
exposure. Furthermore, transgenic (TG) models carrying mutation in candidate genes supports the 
hypothesis that both genetic vulnerability and environmental neurotoxicants converge on 
neuroinflammation as an outcome linked or leading to neurodegeneration.  It is worth noting that 
the very earliest neuronal and pathological changes characteristic of AD suggest oxidative stress as 
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a very early contributor to the disease (Nunomura et al. 2001) and oxidative stress appears to play a 
major role in degeneration of DA neurons in PD (Dias et al. 2013).  
 In the following sections, we will present the more robust experimental studies including 
fetal and/or neonatal exposure to known environmental neurotoxicants, which support the link 
between chemical exposure and hallmarks of neurodegeneration at the adult stage. In many of the 
studies the significant alteration in one or more of these hallmarks was also paralleled by motor 
and/or cognitive disturbances, reproducing in the rodent model the clinical behavioral traits of AD 
and PD affected individuals in the initial stages of the disease. We chose to include in this overview 
also rodent studies exploring the delayed neurobehavioral effects of maternal infection. The 
paradigm of maternal infection models a condition of early immune activation and consequent 
exposure of the fetal brain to pro-inflammatory cytokines: this can affect the development of brain 
circuitries leading to neurobehavioral dysfunctions in the progeny (Knuesel et al. 2014). As shown 
below, studies combining maternal infection with a subsequent toxic insults support the validity of 
the multiple hit hypothesis, as an unfavorable fetal environment increases later vulnerability to 
neurotoxicants. Tables 3.a, 3.b and 3.c illustrate synthetically the experimental studies discussed in 
this chapter.  
 
3.2 Alzheimer’s disease (AD) 
 Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide. The 
main pathological hallmarks of AD are beta-amyloid plaques (Aβ) and neurofibrillary tangles 
(NTFs) composed of hyper phosphorylated tau protein (p-tau), which spread through the cortex in a 
predictable pattern as Alzheimer's disease progresses causing nerve cell degeneration and cognitive 
impairment (Selkoe and Schenk 2003). Early onset familial AD is rare and is characterized by 
autosomal dominant heritability, due to mutations in the genes for APP, presenilin-1 (PSEN1) and 
presenilin-2 (PSEN2). The prevalent form of AD typically develops after 60 years of age; the 
etiology of Late-Onset sporadic AD (LOAD) has not yet been resolved, but it has been suggested 
that it could result from a multifactorial process involving both genetic and environmental factors 
(Reitz et al. 2011). Diseases presenting increased inflammatory processes such as 
hypercholesterolemia, hypertension, atherosclerosis, coronary heart disease, obesity, and diabetes 
are indeed risk factors for AD (Blennow et al., 2006), thus inflammation is suggested to have a 
causal role also in LOAD pathogenesis. Several candidate risk genes have been identified for 
LOAD: they mainly involve proteins implicated in critical pathogenic pathways, namely A 
synthesis and processing, oxidative stress and inflammation/apoptosis (Ballard et al. 2011).  
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 Adverse environmental factors might further increase the risk impose by genetic make-up, 
by acting on cell pathways implicated in AD. Neurotoxic metals such as Pb, Hg, Al, Cd and As, as 
well as some pesticides and metal-based nanoparticles have been involved in AD due to their ability 
to increase Aβ peptide and the phosphorylation of tau protein, causing senile/amyloid plaques and  
(NFTs) characteristic of AD, and to enhance oxidative stress and inflammatory responses (Casado et 
al. 2008). In spite of this consistent evidence, studies considering environmental exposure have 
been underrepresented in the AD literature, possibly due to the challenges of retrospective exposure 
assessment in older adults (Bakulski 2012). 
 
3.2.1 Heavy metals and AD 
Lead 
 Among heavy metals, a large body of clinical data supports an association between 
occupational Pb exposure and cognitive decline with aging as higher levels of Pb in blood and/or 
bone were accompanied by poor cognitive performance in different cognitive tests (Nordberg et al. 
2000; Wright et al. 2003; Weisskopf et al. 2004). Pb is a well-known neurotoxicant in children. 
Even at relatively low and subclinical levels, epidemiologic studies demonstrate prenatal and 
childhood Pb exposure affects IQ and behavior up to young adulthood (Lanphear et al. 2005; 
McFarlane et al. 2013). Recent studies using both in vivo models and primary neuronal cultures 
indicate that Pb exposure during pregnancy may negatively modify important neuronal pathways 
implicated in synaptic plasticity, learning and memory (Neal and Guilarte 2010). In this framework, 
the potential link between developmental exposure to Pb and increased risk of developing AD later 
in life has been thoroughly investigated in experimental studies with rodents and primates.  
 A line of research investigated the link between perinatal Pb exposure, alteration of APP 
metabolism and cognitive impairment at later life stages. Basha and coworkers (2005) exposed rats 
to Pb from birth through postnatal day (PND) 20 by systemic administration and monitored the 
lifetime expression of the APP gene, finding overexpression of APP levels and Aβ aggregation 20 
months after exposure to Pb had ceased. These results have been replicated on monkeys, exposed to 
Pb from birth until the end of the first year of age (Wu et al., 2008). The expression of AD-related 
genes (APP, -site APP cleaving enzyme 1 or BACE1), as well as their transcriptional regulator 
(Sp1) were elevated in aged (23-year old) monkeys following early exposure to Pb. Furthermore, 
levels of amyloid plaques increased in the frontal cortex. These latent effects were paralleled by a 
decrease in DNA methyltransferase activity and higher levels of oxidative damage to DNA, 
indicating that epigenetic mechanisms elicited by Pb in early life influenced the expression of AD-
related genes and promoted DNA damage and pathogenesis.  
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 Bihaqi et al. (2014) evaluated the impact of Pb exposure at different life times (during either 
development or adulthood) on cognitive functions and biochemical pathways associated with AD in 
mice. This study showed that only mice early exposed to Pb, namely during the first 20 days of 
postnatal life through the mother's milk, showed cognitive impairment at 18 months of age, which 
further progressed by 24 months. In Pb-exposed rats, cognitive impairment was accompanied by 
up-regulation of AD biomarkers (APP, and BACE1) and overabundance of p-tau. Long-term 
effects of developmental exposure to Pb has been evaluated also in relation to tau pathology in non 
human primates (Bihaqi & Zawia, 2013). In this study, female monkeys were exposed to Pb (1.5 
mg/kg/day) from birth until the end of the first year of life and then they were examined at 23 years 
of age. Results showed that Pb exposure elevated the mRNA and protein levels of tau as well as its 
transcriptional regulators and favoured abundant tau phosphorylation in the frontal cortex of aged 
primates. This study suggests some evidence that Pb during development triggers 
neurodegenerative processes that have much in common with those implicated in human AD.  
 Due the role of developmental exposure of Pb in increase of Aβ, which is known to generate 
reactive oxygen species in the aging brain, Bolin et al. (2006) investigated the hypothesis that early 
exposure to Pb, in specific developmental window, determines the outcome of oxidative damage 
late in life. Rat pups were exposed to Pb at different ages (from PND 1 to 20 or from 18 to 20 
months), showing that the level of 8-hydroxy-2′-deoxyguanosine (oxo8dG), one of the major 
products of DNA oxidation and a reliable marker of oxidative stress was elevated 20 months after 
exposure to Pb had ceased. The effect of Pb on oxo8 dG levels did not occur if animals were 
exposed to Pb only in old age. These increases in DNA damage occurred in the absence of any Pb-
induced changes in general anti-oxidant capacity in the cerebral cortex.  
 The existence of a critical phase of sensitivity to Pb effects was also supported by other 
studies. Dosunmu et al. (2012) assessed global gene expression patterns in mice, developmentally 
exposed to Pb (0.2%) from gestational day (GD) 13 until PND 20. The selected time points of PND 
20 and 700 represented early and late time points of the animal for microarray analysis, where 
genes that were down- and up-regulated were identified, clustered and analyzed for their 
relationship to DNA methylation. Prior exposure to Pb revealed a repression of genes related to the 
immune response, metal-binding, metabolism and transcription/transduction coupling. More in 
detail, the authors identified 150 genes for a transcriptional profile of normal aging and 
environmentally perturbed aging. In normal aging, those genes are up regulated, but prior 
developmental Pb exposure caused a strong repression of these genes. DNA methylation appears to 
play an important role in the downregulation of these genes suggesting that early life exposure to Pb 
interferes with the methylation pattern of genes and has an impact on the organism's capacity to 
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respond in old age. These findings would support the LEARn model of NDDs, as the toxic effects 
of Pb is maintained through the life span in the form of latent epigenetic changes. 
 Recently Ashok and coworkers (2015) treated rats with a mixture of As+Cd+Pb at 
environmentally relevant concentration, from GD 5 to 6 months of age. They identified dose-
dependent increase of in frontal cortex and hippocampus as early as the post-weaning age. The 
metal mixture activated the pro-amyloidogenic pathway, mediated by increase in APP, and 
subsequent BACE1 and PS-mediated APP processing. Investigating the mechanism of A-induction 
revealed an augmentation in oxidative stress-dependent neuroinflammation that stimulated APP 
expression. When the authors examined the effects of individual metals and binary mixtures in 
comparison with the tertiary mixtures they found that Pb triggered maximum induction of A, 
whereas individual As or Cd had a relatively non-significant effect on A despite enhanced APP. 
Together, these data demonstrate that exposure to As+Cd+Pb induces earlier manifestation of AD-
like pathology that is synergistic, and oxidative stress and inflammation dependent. These data open 
the way to further experimental research modeling real exposure scenarios to mixtures of chemicals. 
 Developmental origin of Pb-induced neurodegenerative disease has been investigated also in 
Zebra fish (Dania rerio), an aquatic vertebrate model system, which presents a high sequence 
homology (i.e., 70%) with the human genome (Howe et al. 2013). Zebrafish are increasingly used 
to understand the mechanisms of developmental Pb neurotoxicity through evaluation of changes in 
gene expression and neurobehavioral alterations (Lee and Freeman 2014). Data collected in this 
model generally supported the hypothesis that developmental exposure to Pb exhibits latent effects 
on the expression of genes that are involved in neurodegenerative processes during old age.  
 
3.2.2 Pesticides and AD 
 Several epidemiological studies have suggested the association between pesticides and 
impairment of cognitive functions and AD-like dementia, but the underlying mechanisms have been 
poorly explored in experimental models (Baldi et al. 2011; Hayden et al. 2010). Among the class of 
pesticides with neurotoxic activity, OPs are the subject of increasing concern. OPs make up 
approximately 50% of all insecticides used in the world (Colborn 2006), and are intensively 
investigated for their suspected developmental neurotoxicity (Rosas and Eskenazi, 2008). These 
compounds, largely used in agriculture, as well as in the home and garden, for pest control, exert 
their acute neurotoxic effects through AChE inhibition and consequent cholinergic stimulation. 
However, increasing evidence indicates that, as other environmental chemicals, OPs exert 
developmental toxicity at low doses with mechanisms different from those observed at higher doses, 
including modulation of several family of genes involved in brain development (Moreira et al. 
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2010). In vitro studies show that OP compounds impair mitochondrial bioenergetics and induce 
ROS generation (Wani et al. 2014). In particular, as concern chlorpyrifos (CPF), the most widely 
applied compound in the OP class in the USA, it interferes with brain and behavior development 
through a variety of cellular and molecular mechanisms that appears as independent from inhibition 
of AChE (Androutsopolous et al. 2013; Eaton et al. 2008; Venerosi et al. 2012).  
 Notwithstanding the recognized effect of this OP insecticide on oxidative stress end points 
(Cole et al 2011), developmental exposure to these compounds has never been considered under the 
perspective of neurodegenerative disease etiology. However, three recent studies using a genetic 
model of vulnerability to AD, the APP TG mice (Tg2576 mice) evidenced a potential increased 
susceptibility to both OP insecticides and bypiridyl herbicide paraquat (PQ). Specifically, CPF 
caused a significant increase in Aβ levels in the cortex and hippocampus, as well as increased 
memory loss and reduced motor activity in Tg2576 mice 6 months after a single subcutaneous 
administration (Salazar et al. 2011), an effect that has not been confirmed by Peris-Sampedro et al. 
(2014). Another study showed that treatment of wild type and Tg2576 mice with PQ (10 
mg/Kg/twice a week/3 weeks) produced a significant increase in Aβ levels in transgenic mice, 
associated with mitochondrial oxidative damage in cerebral cortex and impairment of learning and 
memory. Interestingly, the overexpression of peroxiredoxin 3, a mitochondrial antioxidant defence 
enzyme produced an improvement in cognitive functions and a significant reduction in Aβ levels in 
Tg2576 exposed to PQ (Chen et al. 2012a), suggesting that pro-oxidant xenobiotics like PQ can 
contribute to AD. 
 
3.2.3 Maternal infection and AD 
 As illustrated previously, experimental and clinical data support the inflammation hypothesis 
of AD etiology. It suggests that neuroinflammatory response triggers and follows the A increase in 
the AD brain, and significantly interferes with memory processes (Heneka et al. 2015; Heppner et al. 
2015). The administration of the bacterial endotoxin lipopolysaccharide (LPS) or 
polyinosinic:polycytidylic acid (polyI:C) to pregnant rodents were among the first animal models 
examining the long-term consequences of prenatal immune challenge on adult brain functioning 
(Meyer 2014). In experimental studies, LPS is used to increase pro-inflammatory cytokines in the 
pregnant female’s organism, mimicking an infective state that can induce abnormalities in the fetus 
neurodevelopment (Knuesel et al., 2014).  
 Chen and coworkers (2011) injected female mice with LPS (50 mg/kg) daily during late 
pregnancy (from GD 15 to GD 17). The offspring exposed prenatally to LPS, although showing 
normal development of sensorimotor and cognitive functions, had an accelerated age-related 
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impairment of both spatial and non-spatial learning and memory in middle age. In a subsequent 
study by Krstic et al. (2012) female mice received a single injection of (PolyI:C) (5mg/kg) at GD 17. 
Adult and aged offspring showed cognitive decline and AD-like neuropathology such as increase of 
APP protein and its proteolytic fragments, altered tau phosphorylation, in parallel with impairments 
in working memory. A second immune challenge in adulthood exacerbated this pathological 
phenotype, with appearance of A-like plaque deposition. In this same  study, transgenic AD mice 
(3xTg), overexpressing the human variants of AD-relevant genes, were challenged with PolyI:C at 
the pre-plaque stage of 4 months, and showed accumulation of APP and increase of A deposits 
resembling the morphology of Aplaques in human patients with AD. Taken together, these results 
indicated that systemic immune challenges are able to promote AD-like neuropathology in both 
wild-type (PolyI:C exposure at GD17) and genetically (3xTg-AD) predisposed animals, in 
agreement with both causative and exacerbating role of systemic immune challenges on AD 
development. 
 
3.3 Parkinson’s disease (PD) 
 Parkinson’s disease (PD) is the second most common neurodegenerative disease after AD, 
characterized by depletion of dopaminergic cell bodies in the substantia nigra pars compacta (SNpc) 
with subsequent loss of dopamine (DA) in the nigrostriatal system, and intracytoplasmic inclusions 
termed as Lewy bodies, containing aggregates of the protein α-synuclein as well as other substances 
(Barlow et al. 2007). Studies on familial PD show an autosomic pattern, either dominant or 
recessive, identifying some genetic mutations and chromosal loci responsible for this form. Several 
loci (PARK1-15) and genes have been linked to familial forms of the disease. The majority of PD 
cases are however, sporadic “idiopathic” forms and the recent application of genome-wide 
screening revealed almost 20 genes implicated in mitochondrial function, in detoxification and/or 
protection against oxidative stress that might contribute to disease risk. It is striking that none of the 
genes implicated to date is specifically expressed in DA neurons. Instead, many of the implicated 
genes have rather general neuronal or cellular functions in and outside of the brain, suggesting that 
DA neurons are more susceptible to stress than other neurons (Lees et al., 2009; Westerlund et al., 
2010).  
 The cause of sporadic PD is unknown, with uncertainty about the role of environmental 
toxins and genetic factors. The environmental hypothesis posits that PD-related neurodegeneration 
results from exposure to a dopaminergic neurotoxin. The finding that people intoxicated with the 
chemical 1-methyl-4pheny l-1, 2, 3, 6-tetrahydropyridine (MPTP) developed a syndrome nearly 
identical to PD (Langston et al. 1983) prompted the interest in environmental causes of PD (Tanner 
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et al. 2014). The herbicide PQ is structurally similar to 1-methyl-4-phenylpyridinium (MPP+), the 
active metabolite of MPTP. Similarly to MPP+, the insecticide rotenone is also a mitochondrial 
poison present in the environment. Yet, there are no convincing data to implicate any specific toxin 
as a cause of sporadic PD, and chronic environmental exposure to MPP+ or rotenone is unlikely to 
cause PD per se. Another possibility is that an endogenous toxin may be responsible for PD 
neurodegeneration. Distortions of normal DA metabolism might create toxic substances (i.e. 
reactive oxygen species) because of environmental exposures or inherited differences in metabolic 
pathways (Dauer & Przedborski 2003; Sandy et al. 1996).  
 Several environmental contaminants, known to cause nigrostriatal damage at toxic 
concentrations, could  contribute to PD by interference with mitochondrial respiratory functions and 
ROS generation (Di Monte 2003, Jenner 2003). The insecticides PQ, rotenone and the fungicide 
MB are agricultural chemicals that have each been linked to nigrostriatal damage and the 
emergence of Parkinsonian symptoms, via epidemiological surveys, clinical case reports and/or 
animal models. Exposure to various metals has long been suggested to increase risk of PD, based on 
experimental studies, but human evidence remains inconclusive (Lai et al. 2002; Tanner et al. 2014). 
 
3.3.1 Heavy metals and PD  
Iron 
 Iron (Fe2+), the most abundant metal present in the human brain, has been proposed to play 
a role in the pathogenesis of PD for its pro-oxidants characteristics that may lead to ROS generation 
(Sian-Hulsmann et al., 2011). Several studies have focused on the ability of Fe2+, as well as other 
metals to facilitate the aggregation of the PD-related protein synuclein, but very few studies 
investigated the impact of early exposure to iron on development of PD hallmarks in adult life. In 
the study by Fredriksson and coworkers (1999) at the age of 3 months, offspring exposed in utero to 
Fe2+ (3.7 or 37.0 mg/kg/bw) on GD 10-12, showed marked hypokinesia and lack of habituation in 
spontaneous activity. These effects were more pronounced in mice treated with the higher dose that 
showed also a dose-dependent impaired performance in the radial arm maze. Brain Fe2+ content 
was significantly increased in the basal ganglia, but not in the frontal cortex at the higher dose 
group. In a second study from the same group (Fredriksson et al. 2000) mice were treated in the 
neonatal stage with Fe2+ (7.5 mg/kg/bw) on either PND 3-5, 10-12 or 19-21. Adult mice treated 
with Fe2+ on PND 3-5 and 10–12 showed effects similar to those found after gestational exposure 
on spontaneous motor behavior and learning performance, more marked in animals treated at PND 
10-12. 
 The role of Fe2+ in oxidative stress and superoxide dismutase (SOD) activity may be 
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implicated in the adverse delayed effects of this metal (Dal Pizzol et al. 2001). Male rats were 
treated orally with Fe2+ (7.5 or 15 mg/kg) from PND 10 to 12, measuring at 3 months different 
indexes of oxidative stress. Notably and according to previous clinical and experimental studies, 
this study demonstrated that Fe2+ exposure during a critical neonatal period induced oxidative 
stress and modulated superoxide dismutase (SOD) activity restricted to SN in adult rats. Finally, 
Kaur et al. (2007) investigated the role of early exposure of Fe2+ at a dose (120 µg/g of carbonyl 
iron/BW) equivalent to that found in iron-fortified human infant formula as a risk factor for PD-like 
neurodegeneration. Neonatally exposed mice were challenged at adulthood with the toxin MPTP 
that induces depletion of neostriatal dopamine. Neonatal Fe2+ feeding alone did not induce 
decrease in ST dopamine levels in 2-month-old mice, also when they were challenged with MPTP. 
However, at 12, 16 and 24 months of age mice treated with Fe2+ showed more marked DA 
depletion following acute administration of MPTP than vehicle treated mice. It is worth noting that 
Fe2+ is important for many biological reactions such as the synthesis and release of 
neurotransmitters. In particular, the neonatal period is critical for the establishment of normal Fe2+ 
content in the adult brain and its regional distribution; deficiency such as excess of this metal can 
perturb the typical neurological development. These results highlight the need of epidemiological 
research in humans, especially on the potential long-term effects of Fe2+ supplementation during 
infancy (i.e. milk) on neurological functions in adulthood. 
 
Manganese 
 Manganese (Mn) was related to PD since 1837, when it was noted that high Mn exposures 
caused an extra pyramidal syndrome that resembles the dystonic movements associated with 
parkinsonian symptoms (Couper 1837; Jankovic 2005). Several evidence on the influence of Mn on 
neurodegenerative processes has been collected in in vitro models. A single study comparing in 
vitro and in vivo experiments showed that oxidative stress, mitochondrial dysfunction and 
neuroinflammation are implicated in Mn-induced neurodegeneration (Milatovic et al. 2009). 
 Two experimental studies suggest that early Mn exposure might have profound effects on 
later-life susceptibility to neurotoxins and subsequent degeneration (Cordova et al. 2012, 2013). 
Cordova et al. (2012) show for the first time in vivo the link between early Mn exposure (from PND 
8 to 12) and the modulation of intracellular signalling pathways. Oxidative stress, DA cell death and 
later-life impairment in motor function were also observed. In a subsequent study, the same authors 
investigated the effects of longer exposure to Mn in developing rats. They demonstrated that 
exposure to Mn (5, 10 and 20mg/kg) from PND 8 to 27 caused significant deficits in motor 
21 
Tartaglione, Venerosi and Calamandrei, contribution to "Neurotoxin modelling of brain disorders" 
 
coordination and increased signs of oxidative stress in the ST in rats at 3, 4 or 5 weeks of age 
(Cordova et al., 2013). 
 
3.3.2 Pesticides and PD 
One hit studies 
 Experimental models assessing the causative link between exposure to pesticides and PD-
like neurodegeneration have focused on the effects of environmental toxins on the DA nigrostriatal 
system. This system develops both pre- and postnatally, with receptor development occurring 
predominantly in the postnatal period (Giorgi et al. 1987; Voorn et al. 1988). As described above, 
the chemical structure of the insecticide PQ resembles that of MPP+ , the toxic metabolite that 
mediates the effects of the parkinsonism-inducing agent MPTP. Similarly, administration of PQ to 
mice produces several neurotoxic effects, including damage of the DA nigrostriatal system 
(McComark et al. 2002). Dithiocarbamate fungicides also possess DA activity: maneb (MB) 
administered acutely exacerbates the behavioral symptoms induced by MPTP in mice (hypokinesia 
and catalepsy). Similar effects have been described with the OC herbicide dieldrin, an inhibitor of 
mitochondrial respiration.  
 Richardson et al. (2006) showed that perinatal exposure to low doses of dieldrin (0.3, 1, or 3 
mg/kg every 3 days) during gestation and lactation altered the levels of the dopamine transporter 
(DAT) and vesicular monoamine transporter 2 (VMAT2) at 12 weeks of age.  The alterations of 
both the DA markers were exacerbated by MPTP injections at 12 weeks. Wilson et al. (2014) 
investigated the effects of in utero exposure to endosulfan, an OC insecticide, in male offspring at 3 
months of age. Female mice received endosulfan (1mg/kg/bw) every 2 days from 2 weeks before 
breeding until end of lactation. The authors found a reduced expression of DAT and tyrosine 
hydroxylase (TH) in the striatum (ST) of treated mice, exacerbated by exposure to additional insults 
such as MPTP. Endosulfan failed to cause the same effects when administered at the same dose and 
for the same period to adult mice. These findings indicate that gestation and lactation are critical 
windows of sensitivity to endosulfan exposure and development of nigrostriatal DA system. 
 Two studies evaluated the effects of developmental exposure to the herbicide atrazine (ATR) 
during gestation, lactation and pubertal periods on DA system development (Li et al. 2014; Sun et al. 
2014). The in utero exposure to ATR (25 or 50 mg/kg) from GD 0 to PND 1 reduced the level of 
DA and expression of orphan nuclear hormone (Nurr1), VMAT2, DAT and TH genes in ST and SN, 
respectively, at 6 months of age (Li et al., 2014). In a second study, the authors assessed the effects 
of a more prolonged exposure to ATR given to pregnant mice from GD 5 to PND 22 at the same 
doses of the previous study: DA concentrations and mRNA levels of Nurr1 were decreased in the 
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offspring at 12 months of age. Decreased Nurr1 levels paralleled changes in the mRNA levels of 
VMAT2, which controls the transport and reuptake of DA (Sun et al. 2014). 
 
Two hit studies 
 In line with the double hit hypothesis, it has been suggested that developmental exposure to 
either PQ or MB alone, or in combination, would result in permanent nigrostriatal DA system 
neurotoxicity, and, secondly, it would render this system more susceptible to a second chemical 
challenge later in life. In the study of Thiruchelvam et al. (2002), mice were exposed to PQ, MB 
and PQ+MB from PND 5 to 19 and then re-challenged with the single agents or with the 
combination at 6.5 months of age. Developmental and adult exposure to PQ+MB combination 
produced the greatest damage of the nigrostriatal DA system and a significant reduction in motor 
activity. Furthermore, increased sensitivity to the re-challenge with PQ and MB either alone or in 
combination was observed in only those animals treated neonatally with the combination. Vice 
versa, exposure to PQ or MB alone produced minimal changes but, after adult rechallenge, a 
significant decrease in DA levels and nigral cell count was found, confirming that adult re-exposure 
might un-mask a condition of silent toxicity. Thus, developmental exposures of mice to PQ+MB 
combination led not only to a permanent and selective loss of DA neurons in the SNpc but also 
enhanced the impact of these pesticides administered during adulthood relative to developmental 
only or adult only treatment. Exposure to MB alone during gestation resulted in enhanced response 
to PQ in adulthood, including notable reductions in levels of DA and its metabolites and loss of 
nigral DA neurons, despite the structural dissimilarity and the different mode of action of PQ and 
MB (Cory-Slechta et al. 2005). 
 Another line of research considered the role of in utero exposure to MB, combined with 
subsequent exposure to PQ, in disrupting the nigrostriatal system (Barlow et al. 2004). Pregnant 
mice were exposed to MB or PQ on GD 10-17, at doses ten times lower than that used in young 
adult studies; 2-month-old offspring received either PQ or MB at the doses used for adult mice for 8 
days. .One week after the termination of the second treatment, mice were assessed in a motor 
activity task and then sacrificed to measure brain DA markers. The authors observed only in males 
exposed prenatally to MB and then in the adulthood to PQ, a 95% decrease of locomotor activity, 
associated to decreased levels of striatal DA, increased striatal DA turnover and selective reduction 
in DA neurons of the SNpc. The authors concluded that the sequence of exposures is critical, since 
prenatal exposure to PQ followed by adult challenges with MB failed to produce marked alteration 
of locomotor activity or any DA neuron loss (Barlow et al. 2004). 
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3.3.3 Maternal infection and PD 
 Inflammation and reduced antioxidant defences (i.e. reduced glutathione activity) has been 
implicated in PD pathogenesis (McGeer et al. 2001). Intrauterine infection might lead to nigral cell 
loss in the fetal brain and subsequent permanent decrease in DA neurons, secondary to 
inflammation. In such framework, Zhu et al. (2007) assessed the effects of prenatal LPS exposure 
on glutathione (GSH) metabolism in rat brain. They observed a disturbance of GSH homeostasis in 
offspring of dams administered with LPS at GD 10.5, which possibly makes DA neurons more 
susceptible to the secondary chemical insult. Wang et al. (2009) have observed significant reduction 
of DA and serotonin (5-HT) levels accompanied by loss of DA and 5-HT neurons in SN and in the 
dorsal raphe nucleus (DRN) in adult rats offspring of pregnant dams exposed to a single injection of 
LPS (33 μg/KG) at GD 10.5.  Fan and coworkers (2011a) assessed the effects of intracerebral 
injection of LPS (1 mg/kg) in male rat pups at PND 5. Although on PND 70 rats spontaneously 
recovered the neurobehavioral dysfunction induced by LPS, the authors observed persistent injury 
to DA system and strong inflammatory response including increased activation of microglia and 
inflammatory cytokines in the brain. When challenged with METH (0.5 mg/kg), LPS-exposed rats 
showed increased METH-induced locomotion and stereotyped behaviors as compared to control 
rats. 
 
3.3.4 Multiple hits in PD: maternal infection and chemical insult combination 
 Other their lifespan, human beings are exposed to mixtures of chemicals as well as to 
several non-chemical risk factors. One of the main question in the assessment of the environmental 
hypothesis of PD etiology is whether sequential exposures to different kinds of risk factors across 
the lifetime would result in cumulative neurotoxicity to the nigrostriatal DA system. Various models 
based on "multiple hits" have been developed, assuming that prenatal inflammation makes the brain 
more susceptible to subsequent exposure to DA neurotoxins. 
 The first studies combining maternal infection with exposure to an environmental 
neurotoxicant at a later life stage were carried out by Ling and co-workers (2004). Rats were 
exposed to LPS prenatally, and then administered with a sub-toxic dose of the DA neurotoxin 
rotenone (1.25 mg/kg per day for 14 days) when 16-months old. The combined effects of prenatal 
LPS and postnatal rotenone exposure produced higher DA cell loss compared with the effects of 
single exposure to either LPS or rotenone. Prenatal LPS exposure also led to increased levels of 
oxidized proteins and the formation of -synuclein and eosin-positive inclusions resembling Lewy 
bodies. In the second study, the same authors (Ling et al. 2004) injected on PND 99 the neurotoxin 
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6-hydroxydopamine (6-OHDA) or saline into animals exposed to either LPS or saline prenatally. 
The results showed that animals exposed to prenatal LPS or postnatal 6-OHDA alone had fewer DA 
neurons than controls, while the two toxins combined produced a greater loss. They conclude that 
prenatal exposure to LPS produces permanent cell loss accompanied by an inflammatory state that 
leads to further DA neuron loss once in the presence of subsequent neurotoxin exposure.  
 Fan et al. (2011b) found that neonatal intracerebral injection of LPS following 
administration of rotenone at low dose (1.25 mg/kg/bw) for 14 days from PND 70 resulted in PD-
like neurobehavioral deficits later in life. In agreement with this hypothesis, Tien et al. (2013) 
demonstrated that neonatal LPS exposure enhanced the rotenone-induced accumulation of -
synuclein aggregation and DAT protein expression in the SN. Overall, these studies show that brain 
inflammation in early life may enhance adult susceptibility to develop neurodegenerative hallmarks 
triggered by environmental toxins.  
 To compare the effects of gestational LPS exposure with neonatal systemic LPS exposure on 
adult DA neuron susceptibility to rotenone neurotoxicity, rats was administered with LPS at PND 5 
(Cai et al. 2013), and, at adulthood, were challenged with rotenone at a dose of 1.25 mg/kg per day 
for 14 days. Briefly, rotenone induced loss of DA neurons and PD-like motor impairment in 3-
month-old rats that had experienced neonatal LPS exposure, but not in those without the LPS 
exposure. These results support the view that, although neonatal systemic LPS exposure may not 
necessarily lead to loss of DA neurons in the SN, it could cause persistent functional alterations that 
predispose the nigrostriatal system to be damaged by environmental toxins. 
 Another recent line of evidence concerns air pollution, which has been associated with 
adverse neurological and behavioral effects in children and adults. Increases in neuroinflammation, 
oxidative stress, and glial activation have been identified as putative mechanisms by which air 
pollution exposures may impair central nervous system function in adults. Particulate matter, one of 
many components of ambient outdoor air pollution, causes elevation in cytokines and oxidative 
stress in the brain (Campbell et al. 2009). Given the evidence suggesting susceptibility of both the 
SN and ST to components of air pollution, two studies assessed whether exposure of mice to 
concentrated ambient ultrafine particles (CAPS; <100 nm diameter) during the first two weeks of 
life would alter susceptibility to induction of the PD phenotype by the combined administration of 
PQ+MB, utilizing 10 mg/kg PQ and 30 mg/kg MB 2× per week for 6 weeks (Thiruchelvam et al. 
2000a; Thiruchelvam et al. 2003b). Animals treated with CAPS in the early postnatal period show 
enhanced response to PQ+MB combination. Both CAPS and PQ+MB elevated glutamate levels in 
ST, consistent with potential excitotoxicity. These findings demonstrate the ability of postnatal 
CAPS to produce locomotor dysfunction and dopaminergic and glutamatergic changes, independent 
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of PQ+MB, in brain regions involved in PD (Allen et al., 2014). 
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4. Concluding remarks 
 
 Increasing evidence indicates that events occurring in the earliest stages of human develop-
ment may influence both resilience and vulnerability to several adult diseases, including neuropsy-
chiatric and neurologic disorders. As stated by Olden (2011) the timing of environmental exposure 
is a crucial factor that influences the size of the gene-environment interaction: whereas genes may 
contain the potential for adverse health outcomes, subsequent exposure to environmental triggers is 
required to initiate physiological or pathological pathways responsible for health and disease. 
Experimental models confirm this general view. Research in animals has clearly shown that diverse 
environmental stressors may interfere with typical brain developmental trajectories in critical time 
windows, inducing silent sub-clinical alterations that may hesitate in pathophysiology and overt 
functional (e.g. behavioral) deficits at a later life stage. The bulk of data produced by developmental 
neurotoxicologists since the 1980s has started a series of epidemiological studies to assess the pos-
sible link between sub-toxic exposure to chemical pollutants and neurobehavioral effects in chil-
dren. Thanks to such combined effort, recent advances in research offer important clues into the 
complex etiology of autism and other neurodevelopmental disorders, indicating that developmental 
exposure to chemicals cannot be ruled out (Rossignol et al. 2014). Specifically, variations in candi-
date genes may confer higher individual vulnerability to environmental toxicants. Of note, the con-
vergence of risk factors on the same cell/molecular pathways in critical developmental windows, 
combined with a vulnerable gene makeup, would trigger the development of the disorders or pre-
dispose to adverse health outcome later on. As an example, children at risk for autism may present 
constitutionally reduced antioxidant defenses: this may render the individual more vulnerable to ox-
idative stress and inflammatory processes produced by both xenobiotic exposure and maternal in-
fection during pregnancy (Rose et al., 2012).  
 A similar research effort has not been taking place as concerns the developmental origin of 
NDDs and the role of environmental factors in increasing risk. As discussed in Chapter 1, the long 
latency between exposure and disease occurrence, the difficulty of reconstructing exposures that 
occurred several decades before disease manifestation and the wealth of factors which the individu-
al is exposed to during the life course, makes the developmental origin of NDD a promising but dif-
ficulty provable hypothesis. Nonetheless, given the huge public health impact of NDDs, identifica-
tion of early risk factors would be crucial to design prevention and/or intervention strategies: in this 
perspective, the comprehension of the environmental etiology of major NDDs requires innovative 
study paradigms with multifaceted and multidisciplinary approaches.  
 The experimental findings presented in Chapter 2 prove the utility of in vivo models and 
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support a role of environmental chemicals in increasing risk of NDDs. These experiments showed 
not only that an environmental insult in early life have long-term, irreversible consequences, but 
also that the insult must occur during a critical period in development to have its maximal effect. 
Gestational and neonatal exposure to metals and pesticides as well as experimentally-induced 
maternal infection both lead to alterations in developmental programming that are expressed as an 
irreversibly altered function. The functional effects often include significant motor and/or cognitive 
impairments resembling the pathological phenotypes of major human NDDs. Most of these models 
present strong construct validity, as the more robust hallmarks of AD and PD are associated with the 
functional impairment. Furthermore, epigenetic processes seem to play a key role in the 
mechanisms underlying these phenomena, as shown by the finding that perinatal exposure to Pb 
modulates the expression of AD-related genes, influencing the course of amyloidogenesis and 
oxidative DNA damage via DNA methylation (Dosumnu et al. 2012). Among environmental 
pollutants, Pb is a paradigmatic example of a developmental neurotoxicant able to interfere with 
developmental programming through different and possibly interrelated mechanisms. These include 
the antagonism of NMDA receptors in the early developmental phases, which is the key event at the 
basis of Pb interference with synaptogenesis, neural network formation and behavioral plasticity 
(Toscano and Guilarte 2005); but Pb also induces latent changes in antioxidant defenses and 
mitochondrial redox dysfunction that may trigger neurodegeneration-related pathways at later life 
stages (Caito and Aschner 2015).  
 The experiments assessing the double or multiple hit hypothesis, either by re-challenging the 
animal with the same or a different chemical compound at different life stages or by presenting a 
chemical insult in the adulthood following fetal exposure to maternal inflammation, support the 
LEARn hypothesis advanced by Lahiri et al (2007). The end-result of the fetal insult in fact is an 
animal that is sensitized such that it will be more susceptible to diseases later in life, provided the 
occurrence of a second hit. In such framework, the exposure of the fetal brain to pro-inflammatory 
cytokines secondary to maternal infection appears as a major causative factor of altered 
developmental programming and enhanced vulnerability. This supports the view that 
neurodevelopmental and neurodegenerative disorders do share pathogenic pathways: abnormal 
immune activation in the early stage of brain development may constitute the common event 
predisposing to disease at some point in the lifespan of the individual. 
 The question arising at this point is as to whether experimental findings may help to fill the 
huge gaps in knowledge that lay beneath the developmental hypothesis for NDDs.  Whereas some 
of the studies here reviewed offer interesting clues for the mechanistic underpinnings of chemical-
related effects, experimental models on this topic are still at their beginning.  The very nature of the 
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problem requires the establishment of prospective animal cohorts: this implies the use of develop-
mental exposures with multilevel analysis of the embryos, fetus and pups, as well as of later life 
stages to trace dysfunction/disease. Research must use environmentally relevant doses, dose re-
sponse curves and the examination of the relationship between the molecular mechanism proposed 
and the disease/dysfunction studied.  This would also require the use of the new technologies of 
gene expression profiling and epigenetics: a critical component is the development of a direct corre-
lation and eventually a cause-effect relationship between the alterations in gene expression during 
development (either increased, decreased or inappropriate timing) to alterations in "omic" signa-
tures that may predict a specific disease or dysfunction later in life. To date no available biomarker 
is a clear and validated indicator of typical brain development. Recent studies suggest that placental 
miRNA expression profiles and DNA methylation of specific genes are associated with measures of 
neurobehavioral outcome in the infants as well as with increased risks of neurological and neuro-
degenerative diseases (Sheinerman and Umansky 2013); altered A protein in plasma is related 
with neurodegenerative risk after prenatal Pb exposure (Mazumdar et al. 2012). In vivo models 
could be instrumental to identify robust peripheral biomarkers of exposure, effects and susceptibil-
ity, to be subsequently verified in large prospective human cohort studies to establish biologically 
plausible links between early chemical exposure and later health effects. 
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